These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Molecular genetics and treatment of narcolepsy. Dauvilliers Y, Tafti M. Ann Med; 2006; 38(4):252-62. PubMed ID: 16754256 [Abstract] [Full Text] [Related]
49. [Narcolepsy with and without cataplexy: an uncommon disabling and unrecognized disease]. Merino-Andréu M, Martínez-Bermejo A. An Pediatr (Barc); 2009 Dec; 71(6):524-34. PubMed ID: 19892609 [Abstract] [Full Text] [Related]
52. Effectiveness and optimization of low-sodium oxybate in participants with narcolepsy switching from a high-sodium oxybate: data from the Substitution of Equal Grams of Uninterrupted Xyrem to Xywav study. Macfadden W, Leary EB, Fuller DS, Kirby MT, Roy A. J Clin Sleep Med; 2024 Sep 01; 20(9):1467-1477. PubMed ID: 38652499 [Abstract] [Full Text] [Related]
53. Clinical and therapeutic aspects of childhood narcolepsy-cataplexy: a retrospective study of 51 children. Aran A, Einen M, Lin L, Plazzi G, Nishino S, Mignot E. Sleep; 2010 Nov 01; 33(11):1457-64. PubMed ID: 21102987 [Abstract] [Full Text] [Related]
54. Narcolepsy and effectiveness of gamma-hydroxybutyrate (GHB): a systematic review and meta-analysis of randomized controlled trials. Boscolo-Berto R, Viel G, Montagnese S, Raduazzo DI, Ferrara SD, Dauvilliers Y. Sleep Med Rev; 2012 Oct 01; 16(5):431-43. PubMed ID: 22055895 [Abstract] [Full Text] [Related]
55. Safety and efficacy of long-term use of sodium oxybate for narcolepsy with cataplexy in routine clinical practice. Drakatos P, Lykouras D, D'Ancona G, Higgins S, Gildeh N, Macavei R, Rosenzweig I, Steier J, Williams AJ, Muza R, Kent BD, Leschziner G. Sleep Med; 2017 Jul 01; 35():80-84. PubMed ID: 28619187 [Abstract] [Full Text] [Related]
56. A new indication for gamma hydroxybutyrate (Xyrem) in narcolepsy. Med Lett Drugs Ther; 2006 Jan 30; 48(1227):11-2. PubMed ID: 16444137 [No Abstract] [Full Text] [Related]
57. An interesting case of late age at onset of narcolepsy with cataplexy. Krishnamurthy VB, Nallamothu V, Singareddy R. J Clin Sleep Med; 2014 Feb 15; 10(2):203-5. PubMed ID: 24533004 [Abstract] [Full Text] [Related]
58. Impact of sodium oxybate, modafinil, and combination treatment on excessive daytime sleepiness in patients who have narcolepsy with or without cataplexy. Black J, Swick T, Bogan R, Lai C, Carter LP. Sleep Med; 2016 Aug 15; 24():57-62. PubMed ID: 27810187 [Abstract] [Full Text] [Related]